Any enzyme that depolymerises RNA is a ribonuclease (RNAase). The work described here deals with those classes of RNAase which hydrolyse RNA into smaller oligonucleotide and mononucleotide units at pH optimum 6 5-6 7. Small amounts of an extracellular 'exocrine' form of this RNAase are secreted by the normal human pancreas into the gut.' Reddi and Holland,2 who observed increased levels of serum RNAase in a series of patients with carcinoma of the pancreas, have suggested that this might represent increased enzyme synthesis by proliferating tumour cells within the pancreas. However, Peterson3 has failed to confirm any specificity of elevated serum RNAase in the diagnosis of carcinoma of the pancreas.
We have assessed the potential of this assay to differentiate between carcinoma of the pancreas and other gastrointestinal conditions.
Methods
The method used was the same as that described by Reddi4 with the exception that a precipitant mixture of perchloric acid and uranyl acetate was used instead of perchloric acid and lanthanum nitrate, which proved to be unreliable.
It is not possible to define the enzyme's activity in terms of international units because the molecular weight of the serum polynucleotide is unknown. A spectrophotometric unitage was adopted whereby the optical density (OD) at 250 nm was multiplied by 1000; hence an OD reading of test against blank of0'001 implies 1 spectrophotometric unit of activity. The precision of the assay was quite good for this type of technique (coefficient of variation 7%).
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NORMAL VALUES Serum RNAase level was estimated in 23 healthy adults (age range 20-40 years, 13 women). The upper limit of normal was defined as the normal mean (160 units) plus two standard deviations, ie, 264 units.
Results
Serum RNAase was assayed in 61 patients (Table) . They were stratified into six main diagnostic groups; the distribution of activity in these groups is shown ( Figure) . The serum RNAase level was elevated in all cases of pancreatic carcinoma but elevated levels were not restricted to this condition. In patients with carcinoma of the colon (group C), the incidence and degree of elevation was of the same order as in patients with pancreatic carcinoma (group A). Levels were also elevated in a range of non-malignant 
